EFFECT OF GROWTH-HORMONE (HGH) REPLACEMENT THERAPY ON PHYSICAL WORK CAPACITY AND CARDIAC AND PULMONARY-FUNCTION IN PATIENTS WITH HGH DEFICIENCY ACQUIRED IN ADULTHOOD
R. Nass et al., EFFECT OF GROWTH-HORMONE (HGH) REPLACEMENT THERAPY ON PHYSICAL WORK CAPACITY AND CARDIAC AND PULMONARY-FUNCTION IN PATIENTS WITH HGH DEFICIENCY ACQUIRED IN ADULTHOOD, The Journal of clinical endocrinology and metabolism, 80(2), 1995, pp. 552-557
The effects of 6 months of replacement therapy with recombinant human
GH (hGH) on physical work capacity and cardiac structure and function
were investigated in 20 patients with hGH deficiency of adult onset in
a double blind, placebo-controlled trial. The GH dose of 12.5 mu g/kg
BW was self-administered daily sc. Oxygen consumption (VO2), CO2 prod
uction, and ventilatory volumes were measured during exercise on a bic
ycle spiroergometer. M-Mode echocardiography was performed using stand
ard techniques. The VO, max data, expressed per kg BW (mL/min.kg BW) s
howed a significant increase from 23.2 +/- 2.4 to 30.0 +/- 2.3 (P < 0.
01) in the hGH-treated group, whereas the VO, max data, expressed per
lean body mass (milliliters per min/kg lean body mass) did not change
significantly in either group. Maximal O-2 pulse (milliliters per beat
) increased significantly from 15.2 +/- 5.6 to 19.6 +/- 3.3 ml/beat (P
< 0.01), but remained constant in the placebo group. The maximal powe
r output (watts +/- SE) increased significantly(P < 0.01) from 192.5 /- 13.5 to 227.5 +/- 11.5 in the hGH-treated group, but remained const
ant in the placebo group. Cardiac structure (left ventricular posterio
r wall, interventricular septum thickness, left ventricular mass, left
ventricular endsystolic dimension, and left ventricular end-diastolic
dimension) as well as echocardiographically assessed cardiac function
did not change significantly after 6 months of treatment in either gr
oup. We conclude that hGH replacement in hGH-deficient adults improves
oxygen uptake and exercise capacity. These improvements in pulmonary
parameters might be due to an increase in respiratory muscle strength
and partly to the changes in muscle volume per se observed during hGH
replacement therapy. Furthermore, an increased cardiac output might co
ntribute to the improvement in exercise performance during hGH treatme
nt. According to our data, hGH replacement therapy leads to an improve
ment of exercise capacity and maximal oxygen uptake, but has no signif
icant effect on cardiac structure.